✦ LIBER ✦

Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma

✍ Scribed by Roth, Michael; Linkowski, Marissa; Tarim, John; Piperdi, Sajida; Sowers, Rebecca; Geller, David; Gill, Jonathan; Gorlick, Richard

Book ID: 125455236
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 377 KB
Volume: 120
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.28461

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Midkine as a novel target for antibody t

Midkine as a novel target for antibody therapy in osteosarcoma

✍ Hiroki Maehara; Tadashi Kaname; Kumiko Yanagi; Hiroaki Hanzawa; Ichiro Owan; Tak 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 587 KB

Platelet-derived growth factor receptor

Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma

✍ Tadahiko Kubo; Sajida Piperdi; Jeremy Rosenblum; Cristina R. Antonescu; Wen Chen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB 👁 2 views

## Abstract The purpose of this review was to determine whether imatinib mesylate (STI571, Gleevec) has a role in the treatment of osteosarcoma. The expression of platelet‐derived growth factor (PDGF) receptor and its ligand was examined in a panel of surgical specimens obtained from 54 osteosarcom

Use of botulinum toxin as a diagnostic/

Use of botulinum toxin as a diagnostic/ therapeutic trial to help clarify an indication for definitive therapy in patients with achalasia

✍ David A Katzka; Donald O Castell 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 312 KB

Golimumab, a human anti–tumor necrosis f

Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four–week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

Erratum: Golimumab, a human anti-tumor n

Erratum: Golimumab, a human anti-tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 1 views